Patents by Inventor Anne-Françoise Burnol

Anne-Françoise Burnol has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11020378
    Abstract: The invention relates to a compound inhibiting the interaction between a Grb14 protein and an insulin receptor of Formula (I) or Formula (II), their salts, solvates, and/or diastereoisomers, for use for therapeutic purposes, in particular for the treatment of insulin resistance, and to pharmaceutical compositions containing such compounds.
    Type: Grant
    Filed: March 20, 2018
    Date of Patent: June 1, 2021
    Inventors: Maria Miteva, Bruno Villoutreix, David J. Aitken, Anne-Françoise Burnol, Anais Gondoin, Tarik Issad
  • Publication number: 20200030297
    Abstract: The invention relates to a compound inhibiting the interaction between a Grb14 protein and an insulin receptor of Formula (I) or Formula (II), their salts, solvates, and/or diastereoisomers, for use for therapeutic purposes, in particular for the treatment of insulin resistance, and to pharmaceutical compositions containing such compounds.
    Type: Application
    Filed: March 20, 2018
    Publication date: January 30, 2020
    Inventors: Maria MITEVA, Bruno VILLOUTREIX, David J. AITKEN, Anne-Françoise BURNOL, Anais GONDOIN, Tarik ISSAD
  • Patent number: 6867003
    Abstract: The invention concerns the use of Grb14 and homologous adapting proteins, as tool for screening molecules designed for the treatment of diseases involving insulin. The invention also concerns a method for detecting molecules capable of modulating the tyrosine kinase activity of the insulin receptor.
    Type: Grant
    Filed: March 14, 2000
    Date of Patent: March 15, 2005
    Assignee: Centre National de la Recherche Scientifique
    Inventors: Anne-Françoise Burnol, Dominique Perdereau, Anne Kasus-Jacobi, Véronique Bereziat, Jean Girard